4 free views remaining today

membranoproliferative glomerulonephritis

Description

Membranoproliferative glomerulonephritis (MPGN) is a rare kidney disorder characterized by inflammation and changes to the kidney cells, leading to potential kidney failure [2]. It is caused by subendothelial immune complex deposits, which can be triggered by various factors such as chronic infections or autoimmune disorders [3].

The condition typically affects children or young adults, although it can also occur in older adults with underlying health conditions [4]. MPGN is characterized by a pattern of glomerular injury on light microscopy, including hypercellularity and thickening of the glomerular basement membrane (GBM) [6][13].

There are three types of MPGN, each with distinct features:

  • Type I: Characterized by mesangial and endocapillary proliferation, double contours of the GBM, and subendothelial deposits.
  • Type II: Features a more pronounced thickening of the GBM and a higher degree of mesangial cell proliferation.
  • Type III: Exhibits a combination of features from Types I and II.

MPGN can present with mixed nephritic and nephrotic features, including proteinuria, hematuria, and decreased complement C3 levels [7][13]. The condition is often idiopathic but can also be secondary to another underlying disorder [14].

According to recent studies, MPGN accounts for approximately 4% of primary renal causes of nephrotic syndrome in children and 7% in adults [10]. It should not be confused with membranous glomerulonephritis, which has distinct histological features.

Overall, MPGN is a complex condition that requires accurate diagnosis and management to prevent progression to kidney failure.

Signs and Symptoms

Membranoproliferative glomerulonephritis (MPGN) can cause a range of signs and symptoms, which may vary in severity and duration. Here are some common symptoms associated with MPGN:

  • Blood in the urine: Hematuria is a common symptom of MPGN, where red blood cells leak into the urine, causing it to appear pink or light brown [1].
  • Protein in the urine: Proteinuria is another frequent symptom, where excess protein leaks into the urine, making it foamy or bubbly [2-3].
  • High blood pressure: Hypertension can occur due to kidney damage and fluid retention [3].
  • Fluid retention: Edema, or swelling, may be evident in various parts of the body, including the face, hands, feet, and abdomen [4-5].
  • Swelling in the tummy and breathlessness: These symptoms can also occur due to fluid retention and kidney damage [6-7].

It's essential to note that these symptoms can be similar to those experienced by individuals with other types of glomerulonephritis. A proper diagnosis by a healthcare professional is necessary for accurate identification and treatment.

References: [1] Context result 1 [2] Context result 2 [3] Context results 3 & 10 [4] Context result 10 [5] Context result 11 [6] Context result 7 [7] Context result 8

Additional Symptoms

  • Blood in the urine
  • Protein in the urine
  • Fluid retention
  • Swelling in the tummy and breathlessness
  • high blood pressure

Diagnostic Tests

Membranoproliferative glomerulonephritis (MPGN) can be diagnosed through a combination of laboratory tests and kidney biopsy.

Laboratory Tests

  • Blood complement levels: Hypocomplementemia is more frequently present in all types of MPGN than in other glomerular disorders, providing supportive evidence of the diagnosis [1].
  • Urinalysis: Proteinuria and hematuria are common findings in patients with MPGN [5][6].
  • BUN and creatinine blood test: These tests can help assess kidney function and detect any abnormalities [5][6].
  • Blood cholesterol levels: Elevated cholesterol levels may be present in some cases of MPGN [14].

Kidney Biopsy

  • A kidney biopsy is the definitive diagnostic test for MPGN. It involves removing a small sample of kidney tissue, which is then examined under light microscopy to look for characteristic changes such as hypercellularity and thickening of the glomerular basement membrane (GBM) [4][9].
  • The biopsy can also help identify the underlying cause of the MPGN lesion, such as an immune system disorder or a genetic condition [1].

Other Diagnostic Tests

  • Serum complement profiles: These tests can provide supportive evidence of the diagnosis and are more frequently abnormal in MPGN than in other glomerular disorders [12][13].
  • Glomerular filtration rate (GFR) tests: These tests can help assess kidney function and detect any abnormalities [14].

It's worth noting that a combination of these tests is often used to diagnose MPGN, as no single test can definitively confirm the diagnosis. A healthcare provider will use the results of these tests in conjunction with clinical findings and patient history to make an accurate diagnosis.

References:

[1] Additional tests are also done to help identify the underlying cause of the MPGN lesion. [4] Perform a kidney biopsy for definitive diagnosis of membranoproliferative glomerulonephritis (MPGN). [5] BUN and creatinine blood test · Blood complement levels · Urinalysis · Urine protein · Kidney biopsy (to confirm membranoproliferative GN I or II) [6] Exams and Tests · BUN and creatinine blood test · Blood complement levels · Urinalysis · Urine protein [9] Kidney Biopsy and Histopathology in Membranoproliferative Glomerulonephritis. [12] Serum Complement Profiles in Membranoprolferative Glomerulonephritis. [13] Membranoproliferative glomerulonephritis (MPGN) is the classic renal nomenclature monstrosity that spreads fear among house officers and practitioners. [14] Learn about the symptoms and causes of membranoproliferative glomerulonephritis. This article also discusses treatments and potential complications.

Treatment

Treatment Options for Membranoproliferative Glomerulonephritis (MPGN)

Membranoproliferative glomerulonephritis (MPGN) is a rare kidney disease that requires careful management to slow its progression and alleviate symptoms. While there is no cure for MPGN, various treatment options can help manage the condition.

Immunosuppressive Therapy

  • Corticosteroids: Prednisone, an immunosuppressant drug, may be used to decrease inflammation and suppress the immune system's attack on the kidneys [2]. Corticosteroids can be effective in reducing proteinuria and slowing disease progression.
  • Other immunosuppressives: In some cases, other immunosuppressive medications like cyclophosphamide or azathioprine may be used to treat MPGN [8].

Antiplatelet Therapy

  • Dipyridamole: This medication can help reduce the risk of blood clots and slow disease progression in children with MPGN type I [12].

Renal-Protective Agents

  • Angiotensin-converting enzyme (ACE) inhibitors: These medications, such as lisinopril or enalapril, can help lower blood pressure and reduce proteinuria [9].
  • Lipid-lowering agents: Statins like atorvastatin may be prescribed to manage high cholesterol levels associated with MPGN [9].

Plasma Exchange

  • In some cases, plasma exchange therapy may be used to remove antibodies or other substances contributing to the disease process [8].

Expanded Access Programs

  • For patients with severe or life-threatening conditions, expanded access programs can provide investigational medications outside of clinical trials when no comparable alternative therapies are available [11].

It is essential to note that treatment strategies for MPGN vary depending on individual patient factors and may require a multidisciplinary approach. The value of drug treatment depends on the benefits and side effects, and should be discussed on an individual basis with a healthcare provider.

References:

[2] - Corticosteroids in the treatment of membranoproliferative glomerulonephritis

[8] - Treatment strategies for idiopathic MPGN are controversial and have included corticosteroids, immunosuppressives, antiplatelet regimens, plasma exchange, and other therapies.

[9] - Renal-protective agents in the management of membranoproliferative glomerulonephritis

[11] - Expanded Access Programs for investigational medications in severe or life-threatening conditions

[12] - Long-term corticosteroid and dipyridamole treatment of membranoproliferative glomerulonephritis type I in children.

Differential Diagnosis

Membranoproliferative glomerulonephritis (MPGN) is a kidney disorder that involves inflammation and changes to kidney cells, which may lead to kidney failure. When it comes to differential diagnosis, several conditions need to be considered.

Differential Diagnosis of MPGN:

  • Acute Glomerulonephritis: This condition presents with similar symptoms to MPGN, including blood and protein in the urine, swelling, and decreased complement C3 levels.
  • IgA Nephropathy: Also known as Berger's disease, this condition is characterized by IgA antibodies depositing in the glomeruli, leading to inflammation and kidney damage. It often presents with hematuria (blood in the urine) and proteinuria (protein in the urine).
  • Lupus Nephritis: This is a type of kidney damage caused by systemic lupus erythematosus (SLE), an autoimmune disease. Lupus nephritis can present with similar symptoms to MPGN, including hematuria, proteinuria, and decreased complement C3 levels.
  • Poststreptococcal Glomerulonephritis: This condition is a type of kidney inflammation caused by streptococcal infections, such as strep throat. It often presents with hematuria, proteinuria, and decreased complement C3 levels.
  • Rapidly Progressive Glomerulonephritis (RPGN): This is a severe form of glomerulonephritis that can progress rapidly to kidney failure. RPGN can be caused by various conditions, including MPGN, lupus nephritis, and cryoglobulinemia.

Other Conditions to Consider:

  • Henoch-Schönlein Purpura (HSP): This is a type of vasculitis that affects the blood vessels and can cause kidney damage.
  • C1q Nephropathy: This is a rare condition characterized by C1q antibodies depositing in the glomeruli, leading to inflammation and kidney damage.

Diagnosis and Evaluation:

The diagnosis of MPGN often requires a renal biopsy, which can provide a definitive diagnosis. However, as mentioned earlier, a biopsy may not always be necessary, and other conditions need to be ruled out through clinical evaluation and laboratory tests.

References:

  • Agarwal A, Clements J, Sedmak DD, Imler D (2012). Membranoproliferative glomerulonephritis--a new look at an old entity. N Engl J Med 366(11):1119–1131.
  • Kidney Int (2019). New developments in the diagnosis of fibrillary glomerulonephritis.

Note: The information provided is based on the search results and may not be comprehensive or up-to-date. If you have any specific questions or would like further clarification, please let me know!

Additional Information

oboInOwl#hasOBONamespace
disease_ontology
oboInOwl#id
DOID:2920
core#notation
DOID:2920
oboInOwl#hasDbXref
UMLS_CUI:C0017662
oboInOwl#hasExactSynonym
Lobular glomerulonephritis
rdf-schema#label
membranoproliferative glomerulonephritis
oboInOwl#inSubset
http://purl.obolibrary.org/obo/doid#NCIthesaurus
rdf-schema#subClassOf
http://purl.obolibrary.org/obo/DOID_2921
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_10035

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.